Qiming Venture Partners

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong and Singapore, and a global arm through Qiming Venture Partners USA. It manages multiple funds and invests in early and growth-stage companies across technology, information technology, healthcare, new consumer sectors, AI, robotics, semiconductors, software and digital health. The firm emphasizes a hands-on approach, often taking board seats and providing operational guidance to help CEOs scale and reach exits. Through its investments, it has backed hundreds of companies and supported numerous IPOs and M&A outcomes, with unicorns among its portfolio, illustrating breadth and depth across China and international markets.

Artavazd Arumov Ph.D

Principal

Cyrus Chan

Associate

Nan Chen

Principal

David Chu

Partner

Phillip DiGiacomo Ph.D

Principal

Past deals in Wearables

Shennapsi Artificial Intelligence Technology

Series A in 2023
Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.

Hochuen Medical

Series B in 2023
Hochuen Medical USA Corp., established in 2015 by industry veterans Dr. Robin Liu and Eric Zeng, specializes in the design, development, and mass production of medical devices and consumables as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM). The company focuses on In Vitro Diagnostics (IVD), wearable medical technology, and microfluidic devices, with a portfolio including COVID-19 testing kits and various medical disposables. Hochuen Medical operates as a Contract Development and Manufacturing Organization (CDMO), producing high-quality products such as microfluidic biochips, IVD disposable consumables, point-of-care testing kits, and gene sequencing chips for clients worldwide. The company is committed to quality, holding FDA registration and ISO certifications, and aims to contribute innovative solutions to the healthcare industry through continuous research and development.

Shennapsi Artificial Intelligence Technology

Series A in 2022
Synapsor is a medical-grade wearable device research and development company, oriented to the AI+ medical and health field, and is committed to the development and manufacturing of AI-powered medical-grade smart wearable devices, including AI-ECG artificial intelligence. Diagnostic analysis system, CUMS uric acid blood glucose and cholesterol monitoring system, etc. The company has recently received tens of millions of yuan in Series B investment, and the investor is Xiaomi Technology.

Bio-Link

Series A in 2022
Bio-Link is a drug development company founded in 2001 and headquartered in Shanghai, China. It specializes in providing bioprocessing solutions for the life science industry, including the development and manufacturing of key process equipment and consumables. Bio-Link's offerings include technologies for vaccines, antibody drugs, cell therapy, gene therapy, and various biologics. The company focuses on upstream cell culture, disposable dispensing reservoirs, and downstream processes such as chromatography and ultrafiltration. By delivering innovative products and services, Bio-Link aims to enhance the efficiency, safety, and competitiveness of the biopharmaceutical supply chain. Additionally, the company explores wearable technology solutions for elderly care, further diversifying its portfolio.

Deep View Technology

Series B in 2022
Deep View Technology specializes in motion capture and augmented reality (AR) and virtual reality (VR) applications. The company focuses on research and development in three-dimensional computer vision algorithms, utilizing wearable devices to identify and capture human gestures and postures in real time. This innovative approach enables clients to enhance their VR experiences by accurately translating physical movements into digital environments, thus facilitating a more immersive interaction with technology.

Hochuen Medical

Series A in 2021
Hochuen Medical USA Corp., established in 2015 by industry veterans Dr. Robin Liu and Eric Zeng, specializes in the design, development, and mass production of medical devices and consumables as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM). The company focuses on In Vitro Diagnostics (IVD), wearable medical technology, and microfluidic devices, with a portfolio including COVID-19 testing kits and various medical disposables. Hochuen Medical operates as a Contract Development and Manufacturing Organization (CDMO), producing high-quality products such as microfluidic biochips, IVD disposable consumables, point-of-care testing kits, and gene sequencing chips for clients worldwide. The company is committed to quality, holding FDA registration and ISO certifications, and aims to contribute innovative solutions to the healthcare industry through continuous research and development.

Just Medical

Series B in 2021
Just Medical is a developer and manufacturer of artificial orthopedic implant devices and systems, specializing in products such as artificial hip and knee joints, internal fixation products, and orthopedic surgical instruments. The company is dedicated to enhancing surgical efficiency and improving the quality of orthopedic treatment through advanced technology research and development. Just Medical focuses on creating safe and effective medical products and services, continually refining its product system to address the needs of healthcare providers and alleviate patient pain. Its commitment to high-speed development and excellence positions it as a key player in the orthopedic medical device industry.

Bouffalo Lab

Series B in 2021
Bouffalo Lab is a semiconductor chip design company based in Shanghai, China, specializing in integrated Wi-Fi chipsets and a comprehensive range of Internet of Things (IoT) solutions. The company's semiconductor products cater to various applications, including smart homes, smart cities, intelligent manufacturing, and robotics. Additionally, Bouffalo Lab's chips are utilized in communication equipment, in-vehicle intelligent systems, and wearable devices, enabling efficient low-power wireless microcontrollers and application processor platforms. Through its innovative offerings, Bouffalo Lab supports the development of advanced technologies across multiple sectors.

Element Science

Series C in 2020
Element Science is a medical device and digital health company that develops wearable technologies to address sudden cardiac death risk in high-risk cardiovascular patients. The company designs a wearable cardioverter defibrillator and a digital platform that combines patient-centric human factors, machine learning, and rigorous electromechanical medical device development standards. Its solutions support patients transitioning from hospital to home, providing continuous protection during daily activities such as showering and sleeping. Founded in 2011 and headquartered in San Francisco, Element Science aims to reduce avoidable mortality from heart disease through integrated sensing, analytics, and lifesaving therapy delivered via wearable technology.

Bouffalo Lab

Series B in 2020
Bouffalo Lab is a semiconductor chip design company based in Shanghai, China, specializing in integrated Wi-Fi chipsets and a comprehensive range of Internet of Things (IoT) solutions. The company's semiconductor products cater to various applications, including smart homes, smart cities, intelligent manufacturing, and robotics. Additionally, Bouffalo Lab's chips are utilized in communication equipment, in-vehicle intelligent systems, and wearable devices, enabling efficient low-power wireless microcontrollers and application processor platforms. Through its innovative offerings, Bouffalo Lab supports the development of advanced technologies across multiple sectors.

Bouffalo Lab

Series A in 2018
Bouffalo Lab is a semiconductor chip design company based in Shanghai, China, specializing in integrated Wi-Fi chipsets and a comprehensive range of Internet of Things (IoT) solutions. The company's semiconductor products cater to various applications, including smart homes, smart cities, intelligent manufacturing, and robotics. Additionally, Bouffalo Lab's chips are utilized in communication equipment, in-vehicle intelligent systems, and wearable devices, enabling efficient low-power wireless microcontrollers and application processor platforms. Through its innovative offerings, Bouffalo Lab supports the development of advanced technologies across multiple sectors.

Lanmi

Series A in 2015
Lanmi is a consumer electronics enterprise. It also provides products for wireless audio, smart wear, bone conduction, microphone products, smart wearables, tion, microphone products, smart wearables, IoT, and other categories.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.